London Area, United Kingdom
Experienced Medical Affairs leader (MD/PhD) with 12+ years in clinical practice and a specialist background in paediatric neurology, rare diseases, and genomic medicine. Currently serving as Medical Lead for two therapy areas (Rare Diseases and Inflammation) at Amgen, covering 10 products. I have a proven track record of delivering strategic medical leadership across product lifecycle management, health technology assessment, regulatory engagement, brand strategy, and cross-functional team building. I bring a unique blend of clinical excellence and scientific depth, with hands-on experience in translational research, biomarker development, and clinical trials (Phases I–III). My leadership roles span both academia and industry, including co-investigator responsibilities on AI- and drug repurposing-focused studies at UCL and Great Ormond Street Hospital, where I hold honorary contracts. Recognized for my ability to communicate complex science to diverse audiences, I’ve led international training in neuromuscular genomic medicine, authored publications in high-impact journals, and built global research consortia. My work is deeply rooted in cross-functional collaboration and a strong understanding of the regulatory, commercial, and clinical landscapes that drive success in medical affairs. I thrive in fast-paced, matrix environments and am passionate about driving innovation that transforms patient outcomes. While I have a connection to Amgen, opinions are my own and do not represent Amgen’s position.
Associate Director Level with MSL and SciComms line management covering 10 products in all lifecycle stages across two therapy areas. Final Signatory.
Clinical Research Fellow - International Centre for Genomic Medicine in Neuromuscular Diseases
Paediatric Neurology registrar (GRID) ST7
ST4-5